Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04789434
Status:
UNKNOWN
Last Update Posted:
2021-11-22
First Post:
2021-03-06
Brief Title:
PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chemotherapy |
| Lymphoma Large B-Cell Diffuse |
| Transplantation |
Keywords: